The page lists 1 deliverables related to the research project "BEAt-DKD".
title and desprition | type | last update |
---|---|---|
White paper on strengths and weaknesses of using biomarker panels (or multiple biomarker scores) as risk stratifiers, as targets in drug development and as surrogate endpoints for regulatory approvalMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-02 |
Documents, reports | 2020-04-08 |